Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Total Liabilities (2022 - 2025)

Historic Total Liabilities for Jin Medical International (ZJYL) over the last 4 years, with Q3 2025 value amounting to $23.8 million.

  • Jin Medical International's Total Liabilities rose 3796.07% to $23.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.8 million, marking a year-over-year increase of 3796.07%. This contributed to the annual value of $23.8 million for FY2025, which is 3796.07% up from last year.
  • According to the latest figures from Q3 2025, Jin Medical International's Total Liabilities is $23.8 million, which was up 3796.07% from $20.8 million recorded in Q1 2025.
  • Jin Medical International's Total Liabilities' 5-year high stood at $23.8 million during Q3 2025, with a 5-year trough of $5.7 million in Q3 2022.
  • Moreover, its 4-year median value for Total Liabilities was $15.0 million (2024), whereas its average is $14.1 million.
  • Per our database at Business Quant, Jin Medical International's Total Liabilities surged by 10071.23% in 2024 and then skyrocketed by 3796.07% in 2025.
  • Jin Medical International's Total Liabilities (Quarter) stood at $5.7 million in 2022, then surged by 56.46% to $8.9 million in 2023, then soared by 93.27% to $17.2 million in 2024, then soared by 37.96% to $23.8 million in 2025.
  • Its Total Liabilities was $23.8 million in Q3 2025, compared to $20.8 million in Q1 2025 and $17.2 million in Q3 2024.